Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic Partnership
Sickle Cell Disease Association of America, Inc. (SCDAA) and Hemanext Inc., a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of red blood cell (RBC) transfusion therapy, are proud to announce a new partnership that will help SCDAA deliver on its mission and meet its goals. In 2020 Hemanext will collaborate with SCDAA on its educational programs, grassroots events and public-awareness campaigns.
Sickle cell disease (SCD) affects 100,000 individuals in the United States, disproportionately affecting African Americans with one in 500 African Americans suffering from the disease. People with SCD often require regular blood transfusions, particularly units of RBCs. Hemanext is committed to developing a novel RBC product to deliver improved and longer-lasting transfusions.
+myBinderRelated Content
-
M. Dawn Nelson, PhDDr. M. Dawn Nelson, PhD is an Associate ...
-
New York State Sickle Cell Advocacy Network (NYSSCAN)New York State Sickle Cell Advocacy Netw...
-
Readout From the First Lady’s Roundtable on Improving the Lives of Americans Living With Sickle Cell DiseaseFirst Lady Melania Trump and the Health ...
-
Spectra Optia Device Save Way to Treat Sickle Cell While Using Less Blood Cell Packs, Study FindsThe blood-separation device Spectra Opti...
-
Petition: Implement NIH Guidelines in Hospital Emergency Rooms when Managing a Sickle Cell CrisisHELP US REACH 1,500 E-SIGNATURES BY DECE...
-
Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (...BACKGROUND: Little is known about red b...
-
Sickle Cell Disease Association of Florida, Inc (SCDAF)The Sickle Cell Disease Association of F...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
